论文部分内容阅读
目的：观察在常规抗结核治疗中，联用金葡菌素对抗结核疗效的影响。方法：治疗组４８例在常规抗结核治疗下，联用金葡菌素；另选取４５例常规抗结核治疗的病例作为对照组。结果：治疗组较对照组Ｔ淋巴细胞活性明显增强，总有效率分别为９４％，８０％．结论：金葡菌素是一种可以有效激活Ｔ淋巴细胞的新型蛋白质抗原分子，在常规使用技结核药物治疗肺结核中，联用金葡菌素，可以有效提高抗结核的疗效。
Objective: To observe the effect of Staphylococcus aureus in treating tuberculosis in routine anti-TB therapy. Methods: Forty-eight patients in the treatment group were given Staphylococcus aureus in combination with conventional anti-TB therapy. Another 45 cases of conventional anti-TB therapy were selected as the control group. Results: The activity of T lymphocytes in treatment group was significantly higher than that in control group. The total effective rates were 94% and 80% respectively. CONCLUSION: Staphylocin is a novel protein antigen molecule that can effectively activate T lymphocytes. Staphylococcus aureus can be effectively used in the treatment of pulmonary tuberculosis by routine use of TB drugs, which can effectively improve the anti-TB efficacy.